Rapid growth of the herbal cannabinol market in the USA

The rapid growth of the market for drug-free cannabinoids predetermines the interest in holding a specialized round table, which will consider not only the mechanisms of using cannabigerol, cannabichromene, cannabinol, as well as other natural drug-free cannabinoids for industrial purposes, but also the peculiarities of the regulatory and legal framework of our country regulating the possibilities of use drug-free cannabinoids.

On the pages of the specialized electronic edition of national cannabis growers, the attention of our esteemed readers and listeners has already been focused on the fact that the market for drug-free cannabinoids is actively developing in the economically developed countries of the world and recently there has been a rapid growth in sales volumes and the number of withdrawn products that include cannabigerol. cannabichromen, as well as other therapeutically active elements of the hemp plant “non-traditional” for the market. Despite the fact that “the global market for drug-free cannabinoids is dominated by cannabidiol”The exponential growth of the Cannabinol (CBN / CBN) market in the US has become the basis for a careful study of this issue by our editorial staff. That is why the analytical information provided by our American colleagues will be of interest to our audience.

At the forefront of the use of cannabinol on the market at the moment, its hypnotic properties are put. Despite the fact that the above-mentioned drug-free cannabinoid was discovered almost a century ago, until recently its therapeutic properties were practically not commercialized. Most likely this was due to the rather lengthy and laborious process of KBN production. It is only in the last few years that growers have developed an interest in this non-narcotic cannabinoid of plant origin, and over the past two years there have been rapid changes in the market aimed at introducing a huge number of products that contain cannabinol. 

Sales of CBN-containing products - the vast majority of which are edible - have so far totaled more than $ 65 million in the past four quarters for retailers in California, Colorado, Nevada and Oregon, according to a US-based analyst firm. Specifically, CBN-containing products in California alone reached $ 16.1 million in the second quarter of this year, up 6.6% from the previous quarter and 120% from the third quarter. 2020. Products containing the aforementioned drug-free cannabinoid accounted for 11% of all food sales in California in June 2021, up 6.5% from 2020.

It should be noted that several brands weekly enter the market of the above-mentioned administrative-territorial units of the United States, offering new types of products, the formulation of which includes exactly CBN. For example, a year ago, the aforementioned states had only seven headings that included cannabinol, but that number rose to 55 in the second quarter of 2021, a 20% increase over the first three months of the year.

CBN food sales in Oregon, Nevada and Colorado were virtually nonexistent in June and July 2020, but were already seen at 9.7%, 6.5% and 3.8% in June 2021, respectively, as a percentage of each food market state. The food line in the CBN formulation includes: gummies (top-selling edibles), cookies, mints, chocolate bars, and more.

Commentary of the specialists of the Association "Ukrainian technical hemp"

Cannabinol was discovered in the 1930s and then became the first cannabinoid to be isolated in the 1940s. Despite the fact that this drug-free cannabinoid has a moderate psychotropic effect, until recently, its properties were practically not studied, let alone its use for commercial purposes.

CBN production is a rather complex process. This cannabinoid is found in very small quantities in the plant itself. The drug-free cannabinoid discussed in the article is formed when plants are exposed to prolonged exposure to air and sunlight. As hemp dries and ages, the oxidation process converts individual molecules of another cannabinoid into CBN. Until recently, the period required for the production of cannabinol was significant, which implied a lack of attention on the part of food manufacturers to the properties of this drug-free cannabinoid. The main factors that catalyzed interest in CBN were the huge reserves of unclaimed legal psychoactive cannabis, as well as the good sedative properties of cannabinol, which the market is currently trying to commercialize. In particular, it is expected that in 2020 the market for sleeping pills in the United States will be about $ 31 billion. work towards using cannabinol in order to gain a share of the “sleep market”.

In the course of training the students of the Hemp University since 2019, information is provided on the rapidly growing market of natural plant cannabinoids, their therapeutic properties, as well as formulations for use in various types of food, cosmetics or various kinds of additives (biologically active, feed, food, etc. etc.). The rapid growth of the market for drug-free cannabinoids predetermines the interest in holding a specialized round table, which will consider not only the mechanisms of using cannabigerol, cannabichromene, cannabinol, as well as other natural drug-free cannabinoids for industrial purposes, but also the peculiarities of the regulatory and legal framework of our country, regulating the possibilities of use non-drug cannabinoids.